BEGIN:VCALENDAR
VERSION:2.0
PRODID:Linklings LLC
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
X-LIC-LOCATION:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20210916T132446Z
LOCATION:Henry Dunant
DTSTART;TZID=Europe/Stockholm:20210705T143000
DTEND;TZID=Europe/Stockholm:20210705T150000
UID:submissions.pasc-conference.org_PASC21_sess104_pap135@linklings.com
SUMMARY:Scalable HPC & AI Infrastructure for COVID-19 Therapeutics
DESCRIPTION:Paper\n\nScalable HPC & AI Infrastructure for COVID-19 Therape
 utics\n\nJha\n\nCOVID-19 has claimed more 2.4M lives and resulted in over 
 125M infections. There is an urgent need to identify drugs that can inhibi
 t SARS-CoV-2. We discuss innovations in computational infrastructure and m
 ethods that are accelerating and advancing drug design. Specifically, we d
 escribe several methods that integrate artificial intelligence and simulat
 ion-based approaches, and the design of computational infrastructure to su
 pport these methods at scale. We discuss their implementation and characte
 rize their performance, and highlight science advances that these capabili
 ties have enabled.\n\nDomain: CS and Math, Life Sciences
END:VEVENT
END:VCALENDAR